La Jolla Pharmaceutical Company (LJPC) – Strategy, SWOT and Corporate Finance Report
- Pages: 47
- Published: July 2022
- Report Code: MLPH66490FSA
La Jolla Pharmaceutical Company (LJPC) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
La Jolla Pharmaceutical Company (La Jolla) discovers, develops and commercializes biopharmaceutical products for life-threatening diseases. The company’s major product includes the US FDA approved Giapreza, an injection for intravenous infusion indicated to increase blood pressure in adults with septic or other distributive shock and Xerava (eravacycline), is an injection of tetracycline class antibacterial for the treatment of complicated intra-abdominal infections (cIAI) in adults. Its investigational product candidates include LJPC-0118 intended for the treatment of severe malaria and LJPC-401, a proprietary formulation of synthetic human hepcidin, an endogenous peptide hormone intended for the prevention of excessive iron accumulation in vital organs. The company sells Giapreza to hospitals in the US through a network of wholesale and specialty distributors. La Jolla is headquartered in San Diego, California, the US.
Scope
• Detailed information on La Jolla Pharmaceutical Company required for business and competitor intelligence needs
• A study of the major internal and external factors affecting La Jolla Pharmaceutical Company in the form of a SWOT analysis
• An in-depth view of the business model of La Jolla Pharmaceutical Company including a breakdown and examination of key business segments
• News about La Jolla Pharmaceutical Company, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of La Jolla Pharmaceutical Company and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess La Jolla Pharmaceutical Company as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on La Jolla Pharmaceutical Companys business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
PTC Therapeutics Inc
Par Pharmaceutical Inc
Lexicon Pharmaceuticals Inc
FibroGen Inc
Agios Pharmaceuticals Inc
Acceleron Pharma Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.